Browse Zenopa News Archive

search our vacancies database

Browse by Month:
Jun 2008 | May 2008 | Apr 2008 | Mar 2008 | Feb 2008 | 2007 | Dec 2007 | Nov 2007 | Oct 2007 | Sep 2007 | Aug 2007 | Jul 2007 | Jun 2007 | May 2007 | Apr 2007 | Mar 2007 | Feb 2007 | 2006 | Dec 2006 | Nov 2006 | Oct 2006 | Sep 2006 | Aug 2006 | Jul 2006 | Jun 2006 | May 2006 | Apr 2006 | Mar 2006 | Feb 2006 | 2005 | Dec 2005 | All Dates

Here are the most recent stories:

Long-term breastfeeding 'cuts arthritis risk in half'
Posted on 13/05/2008 in Industry related health news

Women who breastfeed for more than a year are half as likely to develop rheumatoid arthritis (RA) as those who have never breastfed, new research suggests. Read More

Healthcare services for elderly 'not good enough'
Posted on 13/05/2008 in Medical Government/ NHS related news

A survey of doctors has revealed that a majority believe healthcare services for older people are not good enough. Read More

Cardinal Health completes infection prevention acquisition
Posted on 13/05/2008 in Medical Company Restructures

Cardinal Health has announced that it has completed the purchase of the assets of Enturia, a privately-held manufacturer of infection prevention products. Read More

Recordati posts 'positive' first quarter results
Posted on 13/05/2008 in Pharmaceutical Company Financials

Recordati has announced its consolidated financial results for the first quarter of the 2008 fiscal years with the figures being approved by its board of directors. Read More

Forest Laboratories and Daiichi Sankyo announce termination of Azor agreement
Posted on 13/05/2008 in Pharmaceutical Company Product News

Forest Laboratories and Daiichi Sankyo have announced that they have terminated their co-promotion agreement for Azor (amlodipine and olmesartan medoxomil). Read More

Stiefel Laboratories acquires dermal filler developers
Posted on 13/05/2008 in Pharmaceutical Company Restructures

Stiefel Laboratories has announced that it is to purchase ABR Invent and ABR Development, the developers of the Atlean dermal filler. Read More

Shire looks to boost awareness of ADHD
Posted on 13/05/2008 in Pharmaceutical Company Product News

Shire Pharmaceuticals has announced a programme to increase awareness of attention deficit hyperactivity disorder (ADHD) among adults. Read More

ProStrakan announces positive testosterone results
Posted on 13/05/2008 in Pharmaceutical Company Product News

ProStrakan has announced positive results from its pivotal clinical profile for Fortigel (testosterone two per cent gel), known as Tostran in the EU. Read More

Valeant reports first-quarter results
Posted on 13/05/2008 in Pharmaceutical Company Financials

Valeant Pharmaceuticals has published its financial results for the first quarter of the 2008 fiscal year.The firm announced revenues of $194. Read More

Intervet vaccine: Govt expands Bluetongue protection zone
Posted on 12/05/2008 in Veterinary Supplier News

Following the delivery of additional Bluetongue vaccines manufactured by Intervet, the government is to expand the protection zone to allow more extensive vaccination to take place. Read More

Dental school 'discovers new bacteria'
Posted on 12/05/2008 in Dental / Dental Practitioner News

The Glasgow University Dental School claims to have discovered previously unidentified bacteria which cause bad breath. Read More

Scientists make pre-eclampsia breakthrough
Posted on 12/05/2008 in Industry related health news

Scientists have discovered a potential test and treatment target for the pregnancy disorder pre-eclampsia. Read More

Government launches debate on care and support services
Posted on 12/05/2008 in Medical Government/ NHS related news

The Department of Health (DoH) has announced the launch of an intensive six-month debate regarding the future shape of care and support services available on the NHS. Read More

Boston Scientific announces European approval and launch of advanced pacemakers
Posted on 12/05/2008 in Medical Company Product News

Boston Scientific has announced that its Altrua family of pacemakers have received the CE mark of approval and will now be launched in the European market. Read More

MSD announces job losses
Posted on 12/05/2008 in Pharmaceutical Company Restructures

Merck, Sharp and Dohme (MSD) has announced job losses as part of its restructuring plans to improve efficiency. Read More

Forest announces phase III Lexapro data
Posted on 12/05/2008 in Pharmaceutical Company Product News

Forest Laboratories has announced the publication of phase III data for Lexapro (escitalopram oxalate) at the annual meeting of the American Psychiatric Association. Read More

Eli Lilly reports efficacy of ADHD treatment
Posted on 12/05/2008 in Pharmaceutical Company Product News

Eli Lilly has announced that clinicians have received guidance that its attention-deficit hyperactivity disorder (ADHD) drug Strattera (atomoxetine HCl) is effective for up to a year in patients who h... Read More

Bayer and Regeneron start phase III View 2 trial
Posted on 12/05/2008 in Pharmaceutical Company Product News

Bayer and Regeneron have announced the initiation of an additional phase III study for VEGF Trap-Eye study for the treatment of wet age-related macular degeneration (AMD). Read More

Astellas Pharma announces Mycamine approval
Posted on 12/05/2008 in Pharmaceutical Company Product News

Astellas Pharma has announced that its European subsidiary has been granted marketing approval from the European Medicines Agency for Mycamine (micafungin sodium). Read More

Calls for govt to assess polyclinics' effect
Posted on 09/05/2008 in Pharmacy / Pharmacist News

The government should carry out impact assessments when planning polyclinics to ensure local pharmacies are unaffected, an industry body has asserted. Read More

back to the homepage



	Mark Denton Managing Director

Quick Job Search: